Zivo Bioscience, Inc.
ZIVO· OTC
Filed Aug 22, 2011 · 10-Q · 53 days after period end · 0001078782-11-002417
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $27.86K | $19.12K |
| Net Income | -$313.18K | -$21.67K |
| EPS Diluted | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 22, 2011 · 53 d after period end